Antibodies to pancreatic islet cell antigens in diabetes seen in Southern India with particular reference to fibrocalculous pancreatic diabetes

V. Mohan, R. Deepa, E. Bhatia, A. K. Singh, G. A. Hitman, Paul Zimmet, I. R. MacKay

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Fibrocalculous pancreatic diabetes (FCPD) is a type of diabetes secondary to tropical chronic non-alcoholic pancreatitis. Little is known about the aetiopathogenesis of FCPD. We studied glutamic acid decarboxylase antibodies (GAD-Ab) and islet cell antibodies (ICA) in patients with FCPD and compared the results with Type 1 (insulin dependent) diabetes mellitus, Type 2 (non-insulin-dependent) diabetes mellitus and non-diabetic subjects in Southern India. The prevalence of GAD-Ab was 7.0% (95% Confidence Interval (CI) 1.9-17.2) in FCPD, 47.5% (CI 31.4-64.0) in Type 1 (p < 0.001 compared to FCPD), 5.6% (CI 1.5-13.9) in Type 2 (non-significant (NS) compared to FCPD) and 0% in controls. The prevalence of ICA was 6.3% (CI 1.2-17.4) in FCPD, 53.8% (CI 37.1-70.0) in Type 1 (p< 0.001 compared to FCPD), 9.9% (CI 4.0- 19.4) in Type 2 (NS compared to FCPD) and 4.7% (CI 0.4-16.1) in controls. The data suggest that in FCPD, the frequency of auto-antibodies is low and its aetiology is probably not linked to autoimmunity in the majority of the patients.

LanguageEnglish
Pages156-159
Number of pages4
JournalDiabetic Medicine
Volume15
Issue number2
DOIs
Publication statusPublished - 13 Mar 1998

Keywords

  • Diabetes mellitus
  • GAD antibodies
  • Islet cell antibodies
  • Pancreatic diabetes
  • Southern India
  • Type
  • Type 1 diabetes mellitus

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Mohan, V. ; Deepa, R. ; Bhatia, E. ; Singh, A. K. ; Hitman, G. A. ; Zimmet, Paul ; MacKay, I. R. / Antibodies to pancreatic islet cell antigens in diabetes seen in Southern India with particular reference to fibrocalculous pancreatic diabetes. In: Diabetic Medicine. 1998 ; Vol. 15, No. 2. pp. 156-159.
@article{cd9fcd9c58294ce9a32fe07a72bf0c2a,
title = "Antibodies to pancreatic islet cell antigens in diabetes seen in Southern India with particular reference to fibrocalculous pancreatic diabetes",
abstract = "Fibrocalculous pancreatic diabetes (FCPD) is a type of diabetes secondary to tropical chronic non-alcoholic pancreatitis. Little is known about the aetiopathogenesis of FCPD. We studied glutamic acid decarboxylase antibodies (GAD-Ab) and islet cell antibodies (ICA) in patients with FCPD and compared the results with Type 1 (insulin dependent) diabetes mellitus, Type 2 (non-insulin-dependent) diabetes mellitus and non-diabetic subjects in Southern India. The prevalence of GAD-Ab was 7.0{\%} (95{\%} Confidence Interval (CI) 1.9-17.2) in FCPD, 47.5{\%} (CI 31.4-64.0) in Type 1 (p < 0.001 compared to FCPD), 5.6{\%} (CI 1.5-13.9) in Type 2 (non-significant (NS) compared to FCPD) and 0{\%} in controls. The prevalence of ICA was 6.3{\%} (CI 1.2-17.4) in FCPD, 53.8{\%} (CI 37.1-70.0) in Type 1 (p< 0.001 compared to FCPD), 9.9{\%} (CI 4.0- 19.4) in Type 2 (NS compared to FCPD) and 4.7{\%} (CI 0.4-16.1) in controls. The data suggest that in FCPD, the frequency of auto-antibodies is low and its aetiology is probably not linked to autoimmunity in the majority of the patients.",
keywords = "Diabetes mellitus, GAD antibodies, Islet cell antibodies, Pancreatic diabetes, Southern India, Type, Type 1 diabetes mellitus",
author = "V. Mohan and R. Deepa and E. Bhatia and Singh, {A. K.} and Hitman, {G. A.} and Paul Zimmet and MacKay, {I. R.}",
year = "1998",
month = "3",
day = "13",
doi = "10.1002/(SICI)1096-9136(199802)15:2<156::AID-DIA533>3.0.CO;2-E",
language = "English",
volume = "15",
pages = "156--159",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "2",

}

Antibodies to pancreatic islet cell antigens in diabetes seen in Southern India with particular reference to fibrocalculous pancreatic diabetes. / Mohan, V.; Deepa, R.; Bhatia, E.; Singh, A. K.; Hitman, G. A.; Zimmet, Paul; MacKay, I. R.

In: Diabetic Medicine, Vol. 15, No. 2, 13.03.1998, p. 156-159.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Antibodies to pancreatic islet cell antigens in diabetes seen in Southern India with particular reference to fibrocalculous pancreatic diabetes

AU - Mohan, V.

AU - Deepa, R.

AU - Bhatia, E.

AU - Singh, A. K.

AU - Hitman, G. A.

AU - Zimmet, Paul

AU - MacKay, I. R.

PY - 1998/3/13

Y1 - 1998/3/13

N2 - Fibrocalculous pancreatic diabetes (FCPD) is a type of diabetes secondary to tropical chronic non-alcoholic pancreatitis. Little is known about the aetiopathogenesis of FCPD. We studied glutamic acid decarboxylase antibodies (GAD-Ab) and islet cell antibodies (ICA) in patients with FCPD and compared the results with Type 1 (insulin dependent) diabetes mellitus, Type 2 (non-insulin-dependent) diabetes mellitus and non-diabetic subjects in Southern India. The prevalence of GAD-Ab was 7.0% (95% Confidence Interval (CI) 1.9-17.2) in FCPD, 47.5% (CI 31.4-64.0) in Type 1 (p < 0.001 compared to FCPD), 5.6% (CI 1.5-13.9) in Type 2 (non-significant (NS) compared to FCPD) and 0% in controls. The prevalence of ICA was 6.3% (CI 1.2-17.4) in FCPD, 53.8% (CI 37.1-70.0) in Type 1 (p< 0.001 compared to FCPD), 9.9% (CI 4.0- 19.4) in Type 2 (NS compared to FCPD) and 4.7% (CI 0.4-16.1) in controls. The data suggest that in FCPD, the frequency of auto-antibodies is low and its aetiology is probably not linked to autoimmunity in the majority of the patients.

AB - Fibrocalculous pancreatic diabetes (FCPD) is a type of diabetes secondary to tropical chronic non-alcoholic pancreatitis. Little is known about the aetiopathogenesis of FCPD. We studied glutamic acid decarboxylase antibodies (GAD-Ab) and islet cell antibodies (ICA) in patients with FCPD and compared the results with Type 1 (insulin dependent) diabetes mellitus, Type 2 (non-insulin-dependent) diabetes mellitus and non-diabetic subjects in Southern India. The prevalence of GAD-Ab was 7.0% (95% Confidence Interval (CI) 1.9-17.2) in FCPD, 47.5% (CI 31.4-64.0) in Type 1 (p < 0.001 compared to FCPD), 5.6% (CI 1.5-13.9) in Type 2 (non-significant (NS) compared to FCPD) and 0% in controls. The prevalence of ICA was 6.3% (CI 1.2-17.4) in FCPD, 53.8% (CI 37.1-70.0) in Type 1 (p< 0.001 compared to FCPD), 9.9% (CI 4.0- 19.4) in Type 2 (NS compared to FCPD) and 4.7% (CI 0.4-16.1) in controls. The data suggest that in FCPD, the frequency of auto-antibodies is low and its aetiology is probably not linked to autoimmunity in the majority of the patients.

KW - Diabetes mellitus

KW - GAD antibodies

KW - Islet cell antibodies

KW - Pancreatic diabetes

KW - Southern India

KW - Type

KW - Type 1 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=0031906172&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9136(199802)15:2<156::AID-DIA533>3.0.CO;2-E

DO - 10.1002/(SICI)1096-9136(199802)15:2<156::AID-DIA533>3.0.CO;2-E

M3 - Article

VL - 15

SP - 156

EP - 159

JO - Diabetic Medicine

T2 - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 2

ER -